Why does Crohn's disease usually occur in terminal ileum?

Journal of Crohn's and Colitis

Volumn 2, Issue 4, 2008, Pages 352-356

  Caprilli, Renzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adherent invasive Escherichia coli; Autophagy; Crohn's disease; Defensins; IBD; NOD2 CARD15

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ARTICLE; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; CROHN DISEASE; ESCHERICHIA COLI; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; ILEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 56449083160     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2008.06.001     Document Type: Note

References (44)

1. Crohn B.B., Ginzburg L., and Oppenheimer J. Regional ileitis. JAMA 99 (1932) 1232-1239
2. Gasche C., Sholmeric J., Brjenskof J., et al. A simple classification of Crohn's disease: report of a working party of the world congress of gastroenterology Vienna 1998. Inflamm Bowel Dis 6 (2000) 8-15
3. Rutgeerts P., Geboes K., Vantrappen G., et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology 9 (1990) 956-963
4. Mowat A.H. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 3 (2003) 331-341
5. Van Kruiningen H.J., Ganley L.M., and Freda B.J. The role of Peyer's patches in the age-related incidence of Crohn's disease. J Clin Gastroenterol 25 (1997) 470-475
6. Barreau F., Meinzer U., Chareyre F., et al. CARD15/NOD2 is required for Peyer's patches homeostasis in mice. Plosone 2 (2007) e523
7. Ahmad T., Satsangi J., McGovern D., et al. The genetics of inflammatory bowel disease. Aliment Pharmacol Ther 15 (2001) 731-748
8. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., et al. Mapping of susceptibility locus for Crohn's disease on chromosome 16. Nature 379 (1996) 821-823
9. Hugot J.P., Chamaillard M., Zouali H., et al. Association NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
10. Ogura Y., Bonen D.K., Inohara N., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
11. Hampe J., Cuthbert A., Croucher P.J.P., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 (2001) 1925-1928
12. Ahamad T., Armuzzi A., Bunce M., et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 122 (2002) 854-866
13. Cuthbert A.P., Fisher S.A., Mirza M.M., et al. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122 (2002) 867-874
14. Lesage S., Zouali H., Cèzard J.P., et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70 (2002) 845-857
15. Colombel J.F. The CARD15 (also known as NOD2) gene in Crohn's disease: are there implications for current clinical?. Clin Gastroenterol Hepatol 1 (2003) 5-9
16. Guagnozzi D., Cossu A., Viscido A., et al. Acute intestinal obstruction and NOD2/CARD15 mutations among italian Crohn's disease patients. Eur Rew Med Pharmacol Sci 8 (2004) 179-185
17. Ogura Y., Inohara N., Benito A., et al. NOD2, a NOD1/APAF-1 family member that is restricted to monocytes and activates NF-kB. J Biol Chem 276 (2001) 4812-4818
18. Girardin S.E., Sansonetti P.J., and Philpott D.J. Intracellular vs extracellular recognition of pathogens in mammal and flies. Trends Microbiol 10 (2002) 193-199
19. Cho J.H. The NOD2 gene in Crohn's disease: implications for future research into the genetics and immunology of Crohn's disease. Inflamm Bowel Dis 7 (2001) 271-275
20. Rosenstiel P., Fantini M., Brautigam K., et al. TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124 (2003) 1001-1009
21. Hisamatsu T., Suzuki M., Reinecker H.C., et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology (2003) 124:993-1000
22. Berrebi D., Maudinas R., Hugot J.P., et al. CARD15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut 52 (2003) 840-846
23. Caprilli R., and Guagnozzi D. CARD15 and toll-like receptors: the link with Crohn's disease. Dig Liv Dis 35 (2003) 753-757
24. Aderem A., and Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 406 (2000) 782-787
25. Wright S.D. Toll, a new piece in the puzzle of innate immunity. J Exp Med 189 (1999) 605-609
26. Cario E. Toll-like receptor and gastrointestinal disease: from bench to bedside. Curr Opin Gastroenterol 18 (2002) 696-704
27. Wehkamp J., Harder J., Weichenthal M., et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression. Gut 53 (2004) 1658-1664
28. Schroder J.M. Epithelial antimicrobial peptides: innate local host response elements. Cell Mol Life Sci 56 (1999) 32-46
29. Lala S., Ogura Y., Osborne C., et al. Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 125 (2003) 47-57
30. Eckburg P.B., Bik E.M., Bernstein C.N., et al. Diversity of the human intestinal microbial flora. Science 308 (2005) 1635-1638
31. Swidsinski A., Ladhoff A., Pernthaler A., et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 122 (2002) 44-54
32. Darfeuille-Michaud A., Neut C., Barnich N., et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115 (1998) 1405-1413
33. Glasser A.L., Boudeau J., Barnich N., et al. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun 69 (2001) 5529-5537
34. Barnich N., Carvalho F.A., Glasser A., et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 117 (2007) 1566-1574
35. Boudeau J., Barnich N., and Darfeuille-Michaud A. Type 1 pilimedaited adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol 39 (2001) 1272-1284
36. Neut C., Boulois P., Desreumaux P., et al. Changes in the bacterial flora of neoterminal ileum after ileo colonic resection for Crohn's disease. Am J Gastroenterol 97 (2002) 939-946
37. Rutgeerts P., Goboes K., Peeters M., et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338 (1991) 771-774
38. Qu X., Zou Z., Sun Q., et al. Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 128 (2007) 931-946
39. Xavier R.J., Huett A., and Rioux J.D. Autophagy as an important process in gut homeostasis and Crohn's disease pathogenesis. Gut 57 (2008) 717-720
40. Hampe J., Franke A., Rosenstiel P., et al. A genome-wide association scan of nonsynonymous SNPs indentifies a susceptibility variant for Crohn disease in ATG1TL1. Nat Genet 39 (2007) 207-211
41. Prescott N.J., Fisher S.A., Franke A., et al. A Nonsynoymous SNP in ATG16L1 predispose to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology 132 (2007) 1665-1671
42. Van Limbergen J., Russell R.K., Nimmo E.R., et al. Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northen Europe. Inflamm Bowel Dis 14 (2008) 338-346
43. Welcome Trust Care Control Consortiums (WTCCC). Genome wide association study of 14.000 cases if severe common diseases and 3000 shared controls. Nature 447 (2007) 1516-1517
44. Singh S.B., Davis A.S., Taylor G., et al. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313 (2006) 1438-1441